GDR Genedrive Plc

TIDMGDR

RNS Number : 8385W

Genedrive PLC

17 November 2017

For release: 17 November 2017

2017 Annual Report and AGM Notice

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2017 Annual Report and Notice of the 2017 Annual General Meeting have been posted to shareholders. The AGM will be held at 12:00 on 29 November 2017 at the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.

Copies of these documents may be found on the Company's website (www.genedriveplc.com)

- Ends -

For further details please contact:

 
 genedrive plc                         +44 (0)161 989 0245 
 David Budd: CEO 
 Matthew Fowler: CFO 
 
 Peel Hunt LLP 
 James Steel                           +44 (0)207 418 8900 
 Oliver Jackson 
 
 Consilium Strategic Communications    +44 (0)203 709 5700 
 Chris Gardner 
 Matthew Neal 
 Laura Thornton 
 genedrive@consilium-comms.com 
 

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive(R) platform and MTB/RIF test have been launched in India and a Genedrive(R) HCV test has received CE-IVD Certification.

Further details can be found at: www.genedriveplc.com and www.genedrive.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOABBBDBXDBBGRR

(END) Dow Jones Newswires

November 17, 2017 06:25 ET (11:25 GMT)

Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024

Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024